Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

HPV6/11-targeted DNA plasmid vaccine INO-3107

A DNA vaccine consisting of plasmids encoding E6 and E7 genes of human papilloma virus subtype 6 (HPV-6) and 11 (HPV-11), with potential immunostimulating and antineoplastic activities. Upon administration via intramuscular electroporation, the HPV-6/11-targeted DNA plasmid vaccine INO-3107 expresses the HPV-6/11 E6 and E7 proteins, which may elicit a cytotoxic T-lymphocyte (CTL) response against tumor cells that are expressing HPV6 and/or HPV11 E6 and E7 proteins, resulting in tumor cell lysis. HPV-6/11 infections are associated with aerodigestive malignancies.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:HPV-6/11-targeting immunotherapeutic vaccine INO-3107
HPV6/11-targeted DNA plasmid immunotherapeutic INO-3107
Code name:INO 3107
INO-3107
INO3107
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search